tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex
Clinical trial NCT07240272 · COMPLETED
Trial details
- NCT number
- NCT07240272
- Sponsor
- Ke Dong, MD
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2025-05-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.